{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:29:19Z","timestamp":1792384159596,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117631","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T14:56:43Z","timestamp":1744642603000},"page":"117631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Metronidazole-ursodeoxycholic acid bifunctional antibacterial: A promising strategy to combat Clostridium difficile infection and prevent recurrence"],"prefix":"10.1016","volume":"291","author":[{"given":"Kun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Zhu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mohany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-730X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117631_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41467-020-20746-4","article-title":"Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota","volume":"12","author":"Fletcher","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117631_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117631_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00135-23","article-title":"Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options","volume":"37","author":"Di Bella","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2025.117631_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01435-21","article-title":"An aniline-substituted bile salt analog protects both mice and hamsters from multiple Clostridioides difficile strains","volume":"66","author":"Phan","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117631_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117631_bib6","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117631_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13073-024-01306-7","article-title":"Netherlands donor feces bank study group, long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection","volume":"16","author":"Nooij","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.ejmech.2025.117631_bib8","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/jm5016846","article-title":"Clostridium difficile drug pipeline: challenges in discovery and development of new agents","volume":"58","author":"Jarrad","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117631_bib9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117631_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/JEP.S242959","article-title":"Investigational treatment agents for recurrent Clostridioides difficile infection (rCDI)","volume":"12","author":"Kullar","year":"2020","journal-title":"J. Experiment. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117631_bib11","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1021\/acs.jmedchem.0c01198","article-title":"Ultrapotent inhibitor of Clostridioides difficile growth, which suppresses recurrence In Vivo","volume":"63","author":"Naclerio","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117631_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117631_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117631_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-023-01337-7","article-title":"Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut","volume":"8","author":"Foley","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117631_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00045-20","article-title":"Ursodeoxycholic acid (UDCA) mitigates the host inflammatory response during Clostridioides difficile infection by altering gut bile acids","volume":"88","author":"Winston","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ejmech.2025.117631_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure\u2013cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2025.117631_bib17","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved standard-seventh Edition. CLSI Document M11-A7","year":"2007"},{"key":"10.1016\/j.ejmech.2025.117631_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2020.1802865","article-title":"Anti-virulence strategies for Clostridioides difficile infection: advances and roadblocks","volume":"12","author":"Stewart","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ejmech.2025.117631_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.tim.2020.03.004","article-title":"A revised understanding of Clostridioides difficile spore germination","volume":"28","author":"Lawler","year":"2020","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2025.117631_bib20","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","article-title":"A mouse model of clostridium Difficile\u2013Associated disease","volume":"135","author":"Chen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117631_bib21","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/AAC.00360-12","article-title":"Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model","volume":"56","author":"Warren","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117631_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/lam.13664","article-title":"Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting clostridium (clostridioides) difficile","volume":"75","author":"Collins","year":"2022","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117631_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ymthe.2022.10.014","article-title":"Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation","volume":"31","author":"He","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2025.117631_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.934695","article-title":"Akkermansia muciniphila and gut immune system: a good friendship that attenuates inflammatory bowel disease, obesity, and diabetes","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117631_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117631_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01183-22","article-title":"The gut bacterial community potentiates Clostridioides difficile infection severity","volume":"13","author":"Lesniak","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ejmech.2025.117631_bib27","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41467-019-10068-5","article-title":"Bacteroidetes use thousands of enzyme combinations to break Down glycans","volume":"10","author":"Lap\u00e9bie","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117631_bib28","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2020.07.003","article-title":"High-throughput screen identifies host and microbiota regulators of intestinal barrier function","volume":"159","author":"Grosheva","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117631_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.chom.2024.12.002","article-title":"Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization","volume":"33","author":"Fishbein","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2025.117631_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/9780471729259.mc09a01s12","article-title":"Laboratory maintenance of Clostridium difficile","volume":"12","author":"Sorg","year":"2009","journal-title":"Curr. Protoc. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117631_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ijantimicag.2012.07.004","article-title":"Antibiotic susceptibility profiles of oral pathogens","volume":"40","author":"Veloo","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2025.117631_bib32","series-title":"Clostridium difficile","first-page":"117","article-title":"Isolating and purifying Clostridium difficile spores","author":"Edwards","year":"2016"},{"key":"10.1016\/j.ejmech.2025.117631_bib33","series-title":"General Technical Requirements, Pharmacopoeia of the People's Republic of China","author":"Cai","year":"2020"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:51:53Z","timestamp":1778043113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":33,"alternative-id":["S0223523425003964"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117631","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metronidazole-ursodeoxycholic acid bifunctional antibacterial: A promising strategy to combat Clostridium difficile infection and prevent recurrence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117631"}}